Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RIX4414 (Rotarix) Co-administration with OPV in Infants
NCT00139334Phase 2Completed
- Sponsor
- GSK
- Start
- Jun 2005
- Modality
- Live Attenuated Vaccines
- Countries
- 1
01
Overview
A Phase 2 trial of human rotavirus vaccine, live attenuated in rotavirus infection, sponsored by GSK. Started Jun 2005; status: completed.
02
Drugs
human rotavirus vaccine, live attenuated
03
Conditions
rotavirus infection
Beyond the preview
Go deeper on NCT00139334.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00139334.